GDNF and amyotrophic lateral sclerosis: GDNF signaling indisputably possesses potential therapeutic value for several pathologies, such as Parkinson’s disease or amyotrophic lateral sclerosis, among other diseases, where it has been tested using molecular and cellular approaches (Richardson et al., 2011; Thomsen et al., 2014; Rolan et al., 2015).